www.ganeshstock.com 1 | P a g e

DAILY NEWS LETTER

Date: 05.11.2019

Nifty Short Term Trend

The Nifty closed above 11,900 levels on November 4 but

formed a small-bodied candle that resembles a ‘Shooting Star’

formation. The index closed in the green for the seventh

consecutive day. For the bulls to remain in control, the index

has to hold above 11,880 levels on a closing basis. The index is

likely to trade in a range, as it is trading near crucial resistance

levels but there is plenty of action that will be centred around

stock-specific opportunities. The bulls appear to be dragging

their feet on the upside, as the market remained listless for

major part of the trading session, after witnessing a buoyant

opening, which resulted in the slightly longer upper shadow

and resembles a Shooting Star formation. In the next trading

session, if bears manage to pull down the indices below 11,905

levels for at least 30 minutes then it can induce more selling

pressure on an intraday basis until 11,900-11,840, whereas

short term weakness can get confirmed on a close below

11,890 levels while on the higher side immediate resistance can

be seen near 12,000-12,080. Traders to remain neutral on the

index and to shift focus on stock-specific opportunities.

The Bank Nifty continued its positive momentum for the

seventh consecutive session and headed towards 30,600 zones.

However, it failed to hold on to its gains and closed flat near

30,300 zones. Supports are gradually shifting higher and now

the Bank Nifty has to hold above 30,000 zones to head towards

major swing high of 30,500-30,800 zones, while on the

downside, support is seen at 30,000-29750 levels.

Levels to watch

R1 R2 S1 S2 Outlook for the Day Short term Outlook

NIFTY 12000 12080 11900 11840 Sideways Positive

BANK NIFTY 30500 30800 30000 29750 Sideways Positive

USD/INR 70.95 71.20 70.50 70.22 Positive Positive

Capital Market – Daily Newsletter r

www.ganeshstock.com 2 | P a g e

Financial & Economic Wrap Up

ArcelorMittal, on November 4, said it was pulling out

of the purchase of Italy's struggling steel firm Ilva after

parliament scrapped a legal protection deemed

necessary to undertake crucial environmental work

without criminal liability. The Taranto site is at the

centre of a huge legal case in which experts cited by

prosecutors have said some 7,500 people were killed

in the area over seven years by diseases linked to toxic

emissions.

Listed Indian firms' employees, including foreign

nationals, are required to follow the code of conduct

while trading in American Depository Receipts (ADRs)

and Global Depository Receipts (GDRs), the Securities

and Exchange Board of India (SEBI) said on November

4. Trading in such depository receipts is covered under

the Prohibition of Insider Trading (PIT) Regulations,

SEBI clarified.

The Reserve Bank on November 4 issued

compensation guidelines for whole-time directors and

chief executives of foreign, private, small finance,

payments banks and local area banks mandating the

cash component of variable pay at 67 percent. Banks

should continue to formulate and adopt a

comprehensive compensation policy covering all their

employees and conduct annual reviews, RBI said,

adding the new guidelines will be effective next April.

Mahindra & Mahindra (M&M) on November 4 said it is

recalling a limited batch of XUV300 vehicles to fix a

faulty suspension component. The proactive

inspection and replacement of the component would

be carried on a limited batch of compact SUV that was

manufactured till May 19, 2019. "This is in keeping

with the company's customer-centric approach. The

inspection and subsequent rectification will be carried

out free of cost for all XUV300 customers, who will be

individually contacted by the company".

Drug firm Zydus Cadila on November 4 said it has

received a warning letter from the US health regulator

for its Moraiya-based formulation facility. The

company said it has already taken multiple steps after

the inspection of the facility by the US Food and Drug

Administration (USFDA) and would continue to take all

necessary steps in future as well to ensure that the

health regulator is fully satisfied with its remediation

of the above facility.

Indices Performance

Index LTP Previous Close % Change

S&P BSE Sensex 40301.96 40165.03 0.34%

Nifty 50 11941.30 11890.60 0.43%

Nifty Midcap 50 4654.95 4657.45 -0.05%

Nifty 500 9732.40 9704.00 0.29%

Bank Nifty 30333.10 30330.55 0.01%

Institutional Flows (Cash Segment)

Description (Rs in Cr) BUY SELL NET

FII Activity 4625.98 4764.51 -138.53

DII Activity 3297.77 3798.01 -500.24

FIIs Derivative Statistics

BUY SELL

No. of Contracts

Amount (INR. Cr.)

No. of Contracts

Amount (INR. Cr.)

Index Futures 41424 3280.17 42838 3081.05

Index Options 2396903 165894.50 2385236 164807.49

Stock Futures 249860 13611.85 260561 13882.87

Stock Options 88236 4923.25 87465 4896.92 Top OI Gainers

Scrip OI: No of Contracts LTP OI: Value

% Change in OI

APOLLOTYRE 2333 184.25 6999000 18.61

CESC 1151 829.55 920800 14.87

CADILAHC 5526 242.65 8841600 13.33

UBL 3312 1240.3 2318400 11.67

CHOLAFIN 1264 314 3160000 11.17 Top OI Losers

Scrip OI: No of Contracts LTP OI: Value

% Change in OI

BANKINDIA 4131 70.45 24786000 -14.68

DISHTV 6504 14.55 91056000 -9.94

BIOCON 5995 264.1 10791000 -8.02

TORNTPHARM 674 1816 337000 -7.54

HEXAWARE 1175 342.8 1762500 -6.97 Volume Spurt: Cash Segment

Scrip LTP Quantity

Change (%) Price Change

(%)

KNR Constructions 262.45 13.91 12.62

Jindal Steel & Power 137.2 9.29 11.23

Indian Overseas Bank 12 41 10.09

AJANTA PHARMA LTD 1004.5 17.13 -5.49

Dish TV India Limited 14.55 17.05 -10.19 **Change from average Quantity, rest other % are over previous day’s close unless otherwise mentioned

Capital Market – Daily Newsletter r

www.ganeshstock.com 3 | P a g e

Put Call Ratios

OI Wise Volume wise

BOSCHLTD 3.00 BEARISH PVR 3.11 BEARISH

OIL 1.79 BEARISH OIL 2.14 BEARISH

HINDUNILVR 1.39 BEARISH BALKRISIND 2.05 BEARISH

BAJFINANCE 1.29 BEARISH RAMCOCEM 1.71 BEARISH

PFC 1.27 BEARISH HINDUNILVR 1.40 BEARISH

w

0

1,000,000

2,000,000

3,000,000

11200 11400 11600 11800 12000Op

en

Inte

rest

Strike Price

Open Interest-Call/Put

CE-OI PE-OI

-500000

0

500000

1000000

Ch

ange

in IO

Strike Price

Change in Open Interest - Call/Put

Change in OI-CE Change in OI-PE

Nifty OI – Call Put Analysis

F&O Wrap-up

• Nifty October series future closed at 11979.7 Premium of 38.4 Point compared to Nifty spot which closed at 11941.30

• Nifty OI wise Put-Call ratio stood at 1.24 and volume wise put-call ratio stood at 1.23

• India VIX has increased by 1.08 percent and closed at 15.9025

• The open interest in Nifty Futures increased from 13,53,590 to 14,55,700

Quarterly Results Today (Q2)

AJANTA PHARMA LTD. GLOBAL OFFSHORE SERVICES LTD. Precision Camshafts Ltd

APOLLO TYRES LTD. GUJARAT NARMADA VALLEY FERT. & CHEM PRIME URBAN DEVELOPMENT IND.

BERGER PAINTS INDIA LTD. Godrej Properties Ltd Prism Johnson Ltd

BIRLA CORPORATION LTD. GREAVES COTTON LTD. REC Ltd

Cholamandalam Investment and Fin GTL INFRASTRUCTURE LTD. REDINGTON (INDIA) LTD.

COCHIN MALABAR ESTATES & IND. Gujarat Gas Ltd Shantai Industries Ltd

DABUR INDIA LTD. HCL INFOSYSTEMS LTD. Star Cement Ltd

DIVI'S LABORATORIES LTD. INDO RAMA SYNTHETICS (INDIA) LTD. SYSCHEM (INDIA) LTD.

DALAL STREET INVESTMENTS LTD. INDRAPRASTHA MEDICAL CORP.LTD. TRANSPORT CORPORATION

EIH LTD. JINDAL STEEL & POWER LTD. TECH MAHINDRA LTD.

Future Enterprises Ltd MAFATLAL FINANCE CO.LTD. Titan Company Limited

Future Enterprises Ltd_DVR MUKAT PIPES LTD. TORRENT POWER LTD.

GARWARE MARINE INDUSTRIES NCC Limited TRANSCORP INTERNATIONAL LTD.

GATI LTD. NATIONAL FERTILIZERS LTD. TITAGARH WAGONS LTD.

GCCL INFRA. & PROJECTS NIKKI GLOBAL FINANCE LTD.

GE T&D India Ltd P & G HYGIENE & HEALTH CARE

GILLETTE INDIA LTD. PUNJAB NATIONAL BANK

Capital Market – Daily Newsletter r

www.ganeshstock.com 4 | P a g e

Disclosure:

We, research team at Ganesh Stockinvest Pvt. Ltd., authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject

issuer(s) or securities. Ganesh Stockinvest Pvt. Ltd. has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly

or indirectly related to the specific recommendation (s) or view (s) in this report.

Research Analyst or his/her relative or Ganesh Stockinvest Pvt. Ltd. may have any financial interest in the subject company. Also Research Analyst or his relative or Ganesh Stockinvest Pvt. Ltd. or its Associate

may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or

Ganesh Stockinvest Pvt. Ltd. or its associate does not have any material conflict of interest.

Disclaimer:

This report has been prepared by Ganesh Stockinvest Pvt. Ltd. and is meant for sole use by the recipient and not for circulation. The information and opinions contained herein have been compiled or arrived at,

based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as

to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. This document is for information purposes only. Descriptions of any company or companies or

their securities mentioned herein are not intended to be complete and this document is not, and should not be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial

instruments.

This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or

other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject Ganesh Stockinvest Pvt. Ltd. or its affiliates to any registration

or licensing requirement within such jurisdiction.

If this report is inadvertently send or has reached any individual in such country, especially, USA, the same may be ignored and brought to the attention of the sender. This document may not be reproduced,

distributed or published for any purposes without prior written approval of Ganesh Stockinvest Pvt. Ltd..

Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition,

investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk.

It should not be considered to be taken as an offer to sell or a solicitation to buy any security. Ganesh Stockinvest Pvt. Ltd. may from time to time solicit from, or perform broking, or other services for, any company

mentioned in this mail and/or its attachments.

Ganesh Stockinvest Pvt. Ltd. and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned

herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act

as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions.

Ganesh Stockinvest Pvt. Ltd., its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on

basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc.

Ganesh Stockinvest Pvt. Ltd. and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell

or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report.

Ganesh Stockinvest Pvt. Ltd. or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other

assignment in the past twelvemonths.

Ganesh Stockinvest Pvt. Ltd. or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in

respect of managing orco-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course

of business.

Ganesh Stockinvest Pvt. Ltd. or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report.

Accordingly, neither Ganesh Stockinvest Pvt. Ltd. nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any

specific merchant banking, investment banking or brokerage service transactions. Ganesh Stockinvest Pvt. Ltd. may have issued other reports that are inconsistent with and reach different conclusion from the

information presented in this report.

Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any

compensation/benefits from the subject company or third party in connection with the Research Report.